Literature DB >> 25311877

Three-dimensional phase-sensitive inversion recovery sequencing in the evaluation of left ventricular myocardial scars in ischemic and non-ischemic cardiomyopathy: comparison to three-dimensional inversion recovery sequencing.

Tomoyuki Kido1, Teruhito Kido2, Masashi Nakamura2, Naoto Kawaguchi2, Yoshiko Nishiyama2, Akiyoshi Ogimoto3, Masao Miyagawa2, Teruhito Mochizuki2.   

Abstract

BACKGROUND: Late gadolinium enhancement (LGE) magnetic resonance imaging (MRI) is a useful technique for detecting myocardial fibrosis. LGE images are typically acquired using the inversion recovery (IR) method. Recently, phase-sensitive inversion recovery (PSIR) technology has been developed. The purpose of this study was to evaluate free-breathing 3D PSIR sequencing in comparison with breath-held 3D IR sequencing for the detection of myocardial fibrosis.
METHODS: One hundred twenty-three patients with suspected ischemic cardiac disease (n=27) or non-ischemic cardiomyopathy (hypertrophic cardiomyopathy, n=29; dilated cardiomyopathy, n=22; sarcoidosis, n=21; arrhythmia, n=9; myocarditis, n=4; amyloidosis, n=3; and others, n=8) were evaluated by LGE-MRI, which was performed first with the IR sequence and then with the PSIR sequence, using a 3T MRI scanner. Image quality was scored by two independent readers using a four-point scale. The 3D LGE volume was analyzed quantitatively and compared between both sequencing methods.
RESULTS: There was no significant difference in overall image quality (p=0.19). LGE was detected in 73 patients, who were evaluated visually. Ultimately, 58 patients with acceptable image quality were enrolled in further quantitative analyses (volume assessment). Although quantification of LGE volume revealed a strong correlation between both methods, larger LGE volumes were detected with PSIR compared to IR in patients suspected of non-ischemic cardiomyopathy (39.5 ± 25.9 cm(3) for PSIR and 32.8 ± 23.9 cm(3) for IR, p<0.001). The LGE volume did not differ significantly in patients suspected of ischemic cardiac disease (17.9 ± 12.7 cm(3) for PSIR and 17.5 ± 11.1cm(3) for IR, p=0.34).
CONCLUSIONS: 3D PSIR is suitable for detection of LGE and may be an option in cases with IR images of unacceptable quality but overestimates LGE volume in non-ischemic cardiomyopathy.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Late gadolinium enhancement; Magnetic resonance imaging; Myocardial scar; Phase-sensitive inversion-recovery

Mesh:

Substances:

Year:  2014        PMID: 25311877     DOI: 10.1016/j.ejrad.2014.09.014

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  12 in total

1.  T1 mapping using saturation recovery single-shot acquisition at 3-tesla magnetic resonance imaging in hypertrophic cardiomyopathy: comparison to late gadolinium enhancement.

Authors:  Ryo Ogawa; Tomoyuki Kido; Masashi Nakamura; Teruhito Kido; Akira Kurata; Teruyoshi Uetani; Akiyoshi Ogimoto; Masao Miyagawa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2017-01-19       Impact factor: 2.374

2.  Impact of knowledge-based iterative model reconstruction on myocardial late iodine enhancement in computed tomography and comparison with cardiac magnetic resonance.

Authors:  Yuki Tanabe; Teruhito Kido; Akira Kurata; Naoki Fukuyama; Takahiro Yokoi; Tomoyuki Kido; Teruyoshi Uetani; Mani Vembar; Amar Dhanantwari; Shinichi Tokuyasu; Natsumi Yamashita; Teruhito Mochizuki
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-13       Impact factor: 2.357

3.  Three-dimensional maximum principal strain using cardiac computed tomography for identification of myocardial infarction.

Authors:  Yuki Tanabe; Teruhito Kido; Akira Kurata; Shun Sawada; Hiroshi Suekuni; Tomoyuki Kido; Takahiro Yokoi; Teruyoshi Uetani; Katsuji Inoue; Masao Miyagawa; Teruhito Mochizuki
Journal:  Eur Radiol       Date:  2016-08-19       Impact factor: 5.315

4.  Late iodine enhancement computed tomography with image subtraction for assessment of myocardial infarction.

Authors:  Yuki Tanabe; Teruhito Kido; Akira Kurata; Takanori Kouchi; Naoki Fukuyama; Takahiro Yokoi; Teruyoshi Uetani; Natsumi Yamashita; Masao Miyagawa; Teruhito Mochizuki
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

5.  Late gadolinium enhancement cardiac imaging on a 3T scanner with parallel RF transmission technique: prospective comparison of 3D-PSIR and 3D-IR.

Authors:  Anthony Schultz; Thibault Caspar; Mickaël Schaeffer; Aïssam Labani; Mi-Young Jeung; Soraya El Ghannudi; Catherine Roy; Mickaël Ohana
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

Review 6.  Role of Cardiovascular Magnetic Resonance to Assess Cardiovascular Inflammation.

Authors:  Domenico Filomena; Tom Dresselaers; Jan Bogaert
Journal:  Front Cardiovasc Med       Date:  2022-07-06

7.  Improved border sharpness of post-infarct scar by a novel self-navigated free-breathing high-resolution 3D whole-heart inversion recovery magnetic resonance approach.

Authors:  Tobias Rutz; Davide Piccini; Simone Coppo; Jerome Chaptinel; Giulia Ginami; Gabriella Vincenti; Matthias Stuber; Juerg Schwitter
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-22       Impact factor: 2.357

8.  3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography.

Authors:  Giulia Ginami; Radhouene Neji; Imran Rashid; Amedeo Chiribiri; Tevfik F Ismail; René M Botnar; Claudia Prieto
Journal:  J Cardiovasc Magn Reson       Date:  2017-11-27       Impact factor: 5.364

9.  Simultaneous bright- and black-blood whole-heart MRI for noncontrast enhanced coronary lumen and thrombus visualization.

Authors:  Giulia Ginami; Radhouene Neji; Alkystis Phinikaridou; John Whitaker; René M Botnar; Claudia Prieto
Journal:  Magn Reson Med       Date:  2017-07-19       Impact factor: 4.668

10.  Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.

Authors:  Fabian Muehlberg; Kristin Arnhold; Simone Fritschi; Stephanie Funk; Marcel Prothmann; Josephine Kermer; Leonora Zange; Florian von Knobelsdorff-Brenkenhoff; Jeanette Schulz-Menger
Journal:  J Cardiovasc Magn Reson       Date:  2018-02-19       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.